Keuskamp Dominic, Davies Christopher E, Secombe Paul J, Pilcher David V, Chavan Shaila, Jones Sarah L, Reddi Benjamin E, McDonald Stephen P
Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
Crit Care Resusc. 2025 Feb 28;27(1):100099. doi: 10.1016/j.ccrj.2025.100099. eCollection 2025 Mar.
Limited data are available on intensive care unit (ICU) admissions for adults receiving kidney replacement therapy (KRT - dialysis or transplantation) in Australia. Our aim is to characterise admissions for patients receiving long-term dialysis and kidney transplant recipients relative to the general intensive care population in Australia.
Retrospective registry-based data linkage cohort study.
All ICUs in Australia that reported to the Australian and New Zealand Intensive Care Society Adult Patient Database, 1 January 2018-31 December 2020.
All admissions were included. Data were deterministically linked to the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry. Subgroups analysed were defined by sex, age, admission type, APACHE III-j diagnostic category, diabetes status, body mass index (BMI), dialysis modality, dialysis vintage, and kidney transplant vintage.
Admission to ICU for patients receiving KRT at the time of admission (as reported to the ANZDATA Registry).
Patients receiving long-term dialysis prior to admission and those with a kidney transplant numbered 2826 (0.6% of all admissions) and 1194 (0.3%), respectively. Age-sex standardised admission rates relative to the non-KRT cohort (n = 438,271 or 99.1%) were highest for long-term dialysis patients (relative rate 10.18 [95% CI: 9.46,10.93]) and associated with diabetes and sepsis, cardiovascular and respiratory diagnoses.
Rates of ICU admission for people receiving long-term dialysis or kidney transplantation were many times higher than the general population, with particularly increased relative risk among younger age groups and for key medical diagnoses. Given the burden on patients and health services, exploration of strategies to reduce this risk is important.
关于澳大利亚接受肾脏替代治疗(KRT——透析或移植)的成人入住重症监护病房(ICU)的数据有限。我们的目的是描述接受长期透析的患者和肾移植受者相对于澳大利亚普通重症监护人群的入院特征。
基于回顾性登记处的数据链接队列研究。
2018年1月1日至2020年12月31日期间向澳大利亚和新西兰重症监护学会成人患者数据库报告的澳大利亚所有ICU。
纳入所有入院患者。数据通过确定性链接与澳大利亚和新西兰透析与移植(ANZDATA)登记处关联。分析的亚组按性别、年龄、入院类型、APACHE III-j诊断类别、糖尿病状态、体重指数(BMI)、透析方式、透析年限和肾移植年限定义。
入院时接受KRT的患者入住ICU情况(如向ANZDATA登记处报告)。
入院前接受长期透析的患者和肾移植患者分别有2826例(占所有入院患者的0.6%)和1194例(占0.3%)。相对于非KRT队列(n = 438,271例或99.1%),长期透析患者的年龄-性别标准化入院率最高(相对率10.18 [95% CI:9.46,10.93]),且与糖尿病和脓毒症、心血管和呼吸系统诊断相关。
接受长期透析或肾移植的人群入住ICU的比率比普通人群高出许多倍,在较年轻年龄组以及关键医学诊断中相对风险尤其增加。鉴于对患者和医疗服务的负担,探索降低这种风险的策略很重要。